Demolab Event: Lifesaving software, breathtaking careers!

During the Demolab Event you can view software solutions and products that in many cases save or greatly improve the life of patients. Software solutions that will amaze you and are of great importance for society.

ICT Healthcare likes to invite you to this innovative and educational event on Thursday, November 16th at the Gasfabriek in Deventer.
We will show you this evening demonstrations of:
– Clinical Decision Support Systems;
– Workflow and data management systems for hospitals;
– Transplantation system for organs;
– Systems for the treatment of rheumatic diseases;
– Diagnostic systems.

Click here for more information and to sign up.

Sense4Baby: home-monitoring of medical pregnancies

Monitoring the pregnancies of women with health issues is vital to prevent child mortality. But this form of healthcare is also very expensive. Telenatal and BMA, ICT Groups’ IT healthcare specialists, have developed a way to improve monitoring and make it less expensive.

In the NOS journal of Saturday, September 16th you can see a good example of the use of Sense4Baby by a pregnant mother who did her own monitoring, without any help from a nurse or midwife. Specialists at the hospital can check the readings via a web portal. The CTG readings can also be added to the patient’s records in the hospital system via a seperate interface. The Mosos system of BMA.

Please take a look at the website of the NOS journal and watch the item about Sense4Baby.

Press Release: ICT strengthens position in healthcare market

ICT signs letter of intent to acquire the leading software company BMA, specialised in obstetrics solutions

ICT Automatisering N.V. (ICT) announces that today it has signed a letter of intent to acquire the shares of BMA (Bureau Medische Automatisering), a leading Dutch Healthcare software company based in Houten. ICT plans to acquire 51% of the shares as per January 2016. The remaining 49% will be acquired after a period of three years. The purchase consideration comprises a cash payment and an amount paid in ICT shares. The intended acquisition of BMA marks another step in the growth strategy of ICT, as it enables ICT to further expand its position in the healthcare market.

BMA develops software products that are designed for electronic record-keeping and fetal monitoring, focusing on the optimisation of the working and decision-making processes at the maternity ward. Their own software called Mosos – the integral solution for Obstetrics – is developed by BMA in close cooperation with gynaecologists, midwives, universities and government agencies. BMA distinguishes itself by offering all necessary software modules in order to produce paperless synoptic reporting. Next to selling and implementing its software products, BMA is also an exclusive distributor of specific obstetrical hardware products. With some 40 highly skilled professionals, BMA is market leader in the Benelux with a market penetration of approximately 80%. Next to the Benelux market the company is active in the UK, France and Switzerland. In the past years, BMA realised consistent profitable revenues of more than EUR 5 million per annum.

Jos Blejie, CEO of ICT: Diagnostic software and tools are getting increasingly important in the Healthcare sector. This acquisition further enhances our position in the field of ‘Smart Health’. Moreover it fully fits ICT’s strategic objective to become a total solutions provider. BMA is a clear market leader in the field of Obstetrics and enriches the total Health portfolio of ICT.

Oscar Appeldoorn and Alex Holsbergen, Managing Directors of BMA: “Joining ICT, as a leading software integrator, is a next step in realizing our growth strategy. In combination with ICT we expect to accelerate in product development and further internationalization. Staying shareholders in BMA the coming three years, and at the same time becoming a shareholder in ICT underlines the trust we have in a long term relationship with ICT.”

BMA will remain an independent business unit residing in its current location and operating under its own label within the ICT Group.

 

ICT Group (ICT Automatisering N.V.) is an independent provider of industrial automation services. Our specific industry knowledge of various markets, enables us to realize innovative solutions. Over 700 passionate technical specialists are working for the ICT Group. The following subsidiaries are member of the ICT Group: ICT Netherlands (ICT Automatisering Nederland B.V.), Strypes Bulgaria (ICT Nearshoring B.V.), Raster, Improve Quality Services and InTraffic (50%).

www.ict.eu

www.bma-mosos.com

ICT Automatisering delivers process control system for vaccine production at Bilthoven Biologicals

Delivery to biotech company includes new systems for the production of polio vaccines ICT (ICT) has won a contract from biotech company Bilthoven Biologicals in Bilthoven for the delivery of new systems for the production of polio vaccines. In 2014, UNICEF contracted Bilthoven Biologicals for the production of more than 150 million polio vaccines for its “Global Polio Eradication Initiative’ programme. To facilitate production on this huge scale, ICT is currently working on the modernisation of the control systems used for a large proportion of the production equipment. This assignment is subject to the very strict regulations governing the pharmaceutical industry. Martin Bijl, Business Development Manager at ICT: “We are a trusted partner in complex projects in the pharmaceutical industry. This specific project requires know-how of the Siemens PCS7 system and electro-technical expertise in hardware for the system cabinets and installation activities. ICT is therefore extremely proud that it has been given the opportunity to work on this appealing programme to protect children across the globe against infectious diseases like polio.” Joan van Houtum, Senior Buyer at Bilthoven Biologicals: “Bilthoven Biologicals chose to work with ICT following a tender procedure. ICT has a proven track record in projects requiring software control systems as well as hardware and installation. They use a solid project method and offer the right combination of expertise and experience in the pharmaceutical industry.” The contract covers the following tasks: The deliverly and programming of the Siemens PCS7 controllers and control stations; The design, construction and connection of the system cabinets, including wiring to the field signals; Batch control in Simatic Batch; Design and implementation of the recipes. ICT will execute all its tasks in line with ISA standard S88. Bilthoven Biologicals has also closed a multi-year contract with ICT for the service and maintenance of the production automation systems. About Bilthoven Biologicals Bilthoven Biologicals emerged from the privatisation of the vaccine production activities of the former Nederlands Vaccin Instituut (Dutch Vaccine Institute – NVI). In 2012, the owner of the Serum Institute of India, the world’s largest vaccine producer and part of the Cyrus Poonawalla Group, acquired these activities from the NVI. This created a powerful combination of expertise, network and facilities, which Bilthoven Biologicals makes use of to realise its ambitions: protect children across the globe from infectious diseases. This unique cooperation now produces more 100 million vaccines every year. www.bbio.nl